Vladimir K.

Vladimir K. currently serves as the VP of CMC and Technical Operations at AbelZeta, overseeing CMC Development and Technical Operations at the US site, while leading the transformation of the R&D organization into a competent GMP product supply entity for Autologous CAR-T and TIL therapies. As the Founder and Principal of RibbitBio Consulting, LLC, expertise is provided in advisory and consulting services focusing on CMC Development, MS&T, and GMP Manufacturing for various modalities including Biologics, Vaccines, and Cell & Gene Therapies. Previous positions include Head of Manufacturing, MS&T and Supply Chain Operations at BioNTech SE, Site Head of MS&T at Rubius Therapeutics, Global Technology Transfer Lead at Novartis, and other significant roles in leading pharma companies such as Bayer and Novartis, accumulating extensive experience in biomanufacturing and technology transfer. Educational background includes a PhD in Microbiology and Biotechnology from the Institute of Biochemistry and Physiology of Microorganisms, Russian Academy of Science, and an MS in Animal Science/Mycotoxicology from Ryazan State Agricultural Academy in the Russian Federation.